Per Spindler has been named the new president-elect of the Drug Information Association (DIA). The Dane, who is also in charge of the Danish innovation network Biopeople, was elected at the recently held annual meeting of the global association in Boston, MA, and assumed his new position on July 1.

Per Spindler will be a part of DIA’s Executive Committee for the coming three years. The committee also includes Minnie Baylor-Henry, DIA President, Johnson & Johnson Medical Devices & Diagnostics, USA; Ling Su, former President of DIA, Sidley Austin LLP, China; and Jay Roberts, DIA Treasure, AdvantEdge Healthcare Solutions, USA.

From 30 to 18,000

DIA is a global, non-profit organization, offering knowledge resources across the entire spectrum of the development of medicine products and medical equipment.

DIA has a special focus on therapeutic innovation and bureaucratic rules. Since its founding in 1964, the DIA has evolved from a group of 30 professionals from academia and the pharmaceutical industry to a global, multi-disciplinary organization with about 18,000 members in more than 80 countries.

“I am pleased to congratulate Per Spindler on his new position. Per Spindler is competent and experienced and knows all aspects of drug development and innovative networking. He has been an active part of DIA for more than 15 years. I have personally worked with Per Spindler for many years in various contexts in the pharmaceutical sector and have enjoyed highlights such as our joint managing of the European DIA meeting in 2012. I look forward to my continued collaboration with Per Spindler in his capacity as president-elect of the global DIA," says Jytte Lyngvig, President of DIA Europe, in a press release from Biopeople.

- translated by Martin Havtorn Petersen